Joint Annual Meeting ISMRM-ESMRMB 2014 10-16 May 2014 Milan, Italy

Debate: Clinical Utility of MRS in Oncology
SKILL LEVEL: Intermediate to Advanced
ORGANIZERS: Robert E. Lenkinski, Ph.D. & Anwar R. Padhani, M.B.B.S., FRCP, FRCR
Thursday, 15 May 2014
These three methods: CEST, MRI-PET, and MRS each have been applied in the clinical setting to address several important clinical question either in diagnosis and/or monitoring treatment response. Each has its own technical challenges that may have hampered their adoption in widespread clinical studies. This debate will present the motivations for overcoming these challenges and address how they could impact clinical oncology when applied successfully.
Clinicians and Scientists interested in assessing the technical challenges and advantages in applying CEST, MRI-PET and MRS in Clinical Studies.

As a result of attending this course, participants should be able to:

  • Identify the technical barriers inherent in using these methods (CEST, MRI-PET & MRS);
  • Evaluate information derived from each of these approaches and how this information can impact diagnosis and treatment response; and
  • Appraise the prospects of how and when these methods will impact routine clinical use.


Moderator: Anwar R. Padhani, M.B.B.S., FRCP, FRCR

      The MRS Debate  
07:00 Pro-MRS Peter B. Barker, D.Phil.
07:25 Contra-MRS Patrick J. Bolan, Ph.D.
07:50     Adjournment